26 New COVID-19 Cases in Gyeongnam in One Day ... Vaccination Rate at 3%

[Asia Economy Yeongnam Reporting Headquarters, Reporter Ju-cheol In] As of 5 p.m. on the 10th, Gyeongsangnam-do announced that 26 new cases of COVID-19 have been confirmed.

By region, there are 10 cases in Changwon, 6 in Gimhae, 4 in Yangsan, 3 in Jinju, 2 in Haman, and 1 in Namhae. Except for one overseas entrant, all cases are locally transmitted.

Five confirmed cases in Changwon and two in Haman are family members and coworkers of Gyeongnam case number 3078, who was confirmed positive the previous day.

The Changwon cases include a woman in her 40s and a child under 10 who are family members of a man in his 40s confirmed positive the previous day after contact with a Busan case. A woman in her 50s is a family member of a case with an unknown infection route, and a man in his 30s has an unconfirmed infection route.

A man in his 40s in Gimhae showed symptoms while in self-quarantine after contact with a case with an unknown infection route within the province. A man in his 40s, a man in his 50s, and a woman in her 50s are contacts of confirmed cases from Daegu, Busan, and Pocheon in Gyeonggi-do, respectively.

No additional cases were reported at the Gimhae elderly day care center where 21 cases were confirmed in a cluster the previous day.

A man in his 60s in Yangsan is a family member of an overseas entrant confirmed positive the previous day, and two family members including a woman in her 40s are contacts of a Busan case. A man in his 40s has an unconfirmed infection route.

Three cases in Jinju, including two men in their 50s and a woman in her 80s, are all under investigation for infection routes.

A woman in her 70s in Namhae is a contact of a confirmed case from Iksan, Jeonbuk.

Accordingly, the cumulative number of confirmed cases in the province has risen to 3,125 (226 hospitalized, 2,885 discharged, 14 deceased).

The COVID-19 vaccination rate in the province shows about 3%, with approximately 84,300 people, including around 13,300 seniors aged 75 and older, having received the first dose out of 2.8 million eligible individuals aged 18 and above.

This content was produced with the assistance of AI translation services.